BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32933390)

  • 21. Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?
    Viskin S; Fish R; Zeltser D; Belhassen B; Heller K; Brosh D; Laniado S; Barron HV
    Heart; 2000 Jun; 83(6):661-6. PubMed ID: 10814624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Torsade de pointes. Mechanisms and management.
    Napolitano C; Priori SG; Schwartz PJ
    Drugs; 1994 Jan; 47(1):51-65. PubMed ID: 7510621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes.
    Tan HL; Hou CJ; Lauer MR; Sung RJ
    Ann Intern Med; 1995 May; 122(9):701-14. PubMed ID: 7702233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Torsade de pointes.
    El-Sherif N; Turitto G
    Curr Opin Cardiol; 2003 Jan; 18(1):6-13. PubMed ID: 12496496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report.
    Katapadi K; Kostandy G; Katapadi M; Hussain KM; Schifter D
    Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The QT interval and torsade de pointes.
    Moss AJ
    Drug Saf; 1999; 21 Suppl 1():5-10; discussion 81-7. PubMed ID: 10597863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced torsade de pointes. Incidence, management and prevention.
    Faber TS; Zehender M; Just H
    Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
    Lewis BH; Antman EM; Graboys TB
    J Am Coll Cardiol; 1983 Sep; 2(3):426-36. PubMed ID: 6192159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany.
    Elsayed M; Abdel-Kahaar E; Gahr M; Connemann BJ; Denkinger M; Schönfeldt-Lecuona C
    Eur J Clin Pharmacol; 2021 May; 77(5):767-775. PubMed ID: 33230596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsade de pointes and syncopal attacks in a 26-year old woman with congenital complete heart block and prolonged QT interval.
    Quek DK; Ong SB
    Singapore Med J; 1990 Apr; 31(2):185-8. PubMed ID: 2371586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings.
    Locati EH; Maison-Blanche P; Dejode P; Cauchemez B; Coumel P
    J Am Coll Cardiol; 1995 Jun; 25(7):1564-75. PubMed ID: 7539014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Strauss DG; Vicente J; Johannesen L; Blinova K; Mason JW; Weeke P; Behr ER; Roden DM; Woosley R; Kosova G; Rosenberg MA; Newton-Cheh C
    Circulation; 2017 Apr; 135(14):1300-1310. PubMed ID: 28213480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Torsade de pointes.
    Roden DM
    Clin Cardiol; 1993 Sep; 16(9):683-6. PubMed ID: 7902224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Torsade de pointes and long QT syndrome following major blood transfusion.
    Kulkarni P; Bhattacharya S; Petros AJ
    Anaesthesia; 1992 Feb; 47(2):125-7. PubMed ID: 1539780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.